Pump the Brakes on the Illumina and Pacific Biosciences Deal

Pump the Brakes on the Illumina and Pacific Biosciences Deal

Source: 
Motley Fool
snippet: 

When Illumina (NASDAQ: ILMN) announced it had agreed to acquire Pacific Biosciences (NASDAQ: PACB) in November 2018, the already concentrated world of DNA sequencing was bracing for further consolidation.